Epigenetic Regulation of the Expression of T Cell Stimulatory and Inhibitory Factors by Histone H3 Lysine Modification Enzymes and Its Prognostic Roles in Glioblastoma
Authors:
Open Access
- 1 January 2023
- journal article
- research article
- Published by XMLink in Journal of Korean Medical Science
- Vol. 38 (33) , e258
Abstract
Lee SH, et al. J Korean Med Sci. 2023 Aug;38(33):e258. https://doi.org/10.3346/jkms.2023.38.e258Keywords
Funding Information
- National Research Foundation of Korea (NRF 2019R 1F1A 1054681)
- Sungkyunkwan University
- Samsung Changwon Hospital
This publication has 68 references indexed in Scilit:
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in CancerNew England Journal of Medicine, 2012
- The role of EZH2 in tumour progressionBritish Journal of Cancer, 2011
- CD8+ T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survivalJournal of Clinical Neuroscience, 2010
- Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphomaBlood, 2010
- Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinomaBMC Cancer, 2010
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaNew England Journal of Medicine, 2010
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- Epigenetic Control of the foxp3 Locus in Regulatory T CellsPLOS Biology, 2007
- An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme1Neuro-Oncology, 2006
- T-Cell Activation Marker Expression on Tumor-Infiltrating Lymphocytes As Prognostic Factor in Cutaneous Malignant MelanomaClinical Cancer Research, 2004